Posted by Michael Wonder on 21 Dec 2020
Closure of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
21 December 2020 - A plain language summary for the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis is now available.
In addition the webpage has been updated to include:
- A link to the public summary document for the cost effectiveness review of the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
- The Review Report has now been published as final with no changes made from the previously published draft Review Report.
